Advances in bacteria‐based drug delivery systems for anti‐tumor therapy
Clinical & Translational Immunology · 2024-01 · 13 (7)
DOI: 10.1002/cti2.1518 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical & Translational Immunology, online erschienen am 26.06.2024. Verfasst von Han Shuwen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Huzhou Central Hospital Affiliated Central Hospital Huzhou Universityy Huzhou Zhejiang Province China. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
In recent years, bacteria have gained considerable attention as a promising drug carrier that is critical in improving the effectiveness and reducing the side effects of anti‐tumor drugs. Drug carriers can be utilised in various forms, including magnetotactic bacteria, bacterial biohybrids, minicells, bacterial ghosts and bacterial spores. Additionally, functionalised and engineered bacteria obtained through gene engineering and surface modification could provide enhanced capabilities for drug delivery. This review summarises the current studies on bacteria‐based drug delivery systems for anti‐tumor therapy and discusses the prospects and challenges of bacteria as drug carriers. Furthermore, our findings aim to provide new directions and guidance for the research on bacteria‐based drug systems.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Huzhou Central Hospital Affiliated Central Hospital Huzhou Universityy Huzhou Zhejiang Province China.
- Huzhou Central Hospital Fifth Affiliated Clinical Medical College of Zhejiang Chinese Medical University Huzhou Zhejiang Province China.
- Key Laboratory of Multiomics Research and Clinical Transformation of Digestive Cancer of Huzhou Huzhou Zhejiang Province China.
ORCID-Profile: Han Shuwen
Förderung
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Shuwen, H., Yifei, S., Xinyue, W., Zhanbo, Q., Xiang, Y., & Xi, Y. (2024). Advances in bacteria‐based drug delivery systems for anti‐tumor therapy. Clinical & Translational Immunology, 13(7). https://doi.org/10.1002/cti2.1518
Vancouver
Shuwen H, Yifei S, Xinyue W, Zhanbo Q, Xiang Y, Xi Y. Advances in bacteria‐based drug delivery systems for anti‐tumor therapy. Clinical & Translational Immunology. 2024;13(7). doi:10.1002/cti2.1518
BibTeX
@article{Shuwen2024,
author = {Shuwen, Han and Yifei, Song and Xinyue, Wu and Zhanbo, Qu and Xiang, Yu and Xi, Yang},
title = {Advances in bacteria‐based drug delivery systems for anti‐tumor therapy},
journal = {Clinical & Translational Immunology},
year = {2024},
volume = {13},
number = {7},
doi = {10.1002/cti2.1518}
}
EUVIMED